Licensed Meningococcal Serogroup B Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Licensed Meningococcal Serogroup B Vaccine, covering 2021-08-30 to 2021-08-30. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Immune Response After a Booster Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine When Administered Alone or Concomitantly With a Licensed Meningococcal Serogroup B Vaccine, in Participants Who Received Primary Quadrivalent Meningococcal Conjugate Vaccine (MCV4) [Phase 3]